Dr Jeffrey E Schulz, MD | |
Schneck Medical Center, 411 West Tipton Street, Seymour, IN 47274 | |
(812) 524-8346 | |
(812) 524-4231 |
Full Name | Dr Jeffrey E Schulz |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 39 Years |
Location | Schneck Medical Center, Seymour, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659391209 | NPI | - | NPPES |
200003010A | Medicaid | IN | |
000000084531 | Other | IN | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 01038272A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Schneck Medical Center | Seymour, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Jackson County Schneck Memorial Hospital | 8224004585 | 108 |
News Archive
Medical Services International Inc. has announced that the interest by regulatory authorities and the company's distributors has increased substantially for its VScan Dengue Fever and Malaria test kits.
The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
It seems like a no-brainer, and it is: Take the junk food out of school vending machines and cafeterias, and kids will eat less junk food, according to a new study that took place in Connecticut.
Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a cytotoxicity study of its lead compound, Adva-27a, in H69AR, a Multidrug Resistant Small Cell Lung Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro.
› Verified 2 days ago
Entity Name | Jackson County Schneck Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629143037 PECOS PAC ID: 8224004585 Enrollment ID: O20041029000584 |
News Archive
Medical Services International Inc. has announced that the interest by regulatory authorities and the company's distributors has increased substantially for its VScan Dengue Fever and Malaria test kits.
The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
It seems like a no-brainer, and it is: Take the junk food out of school vending machines and cafeterias, and kids will eat less junk food, according to a new study that took place in Connecticut.
Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a cytotoxicity study of its lead compound, Adva-27a, in H69AR, a Multidrug Resistant Small Cell Lung Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey E Schulz, MD Schneck Medical Center, 411 West Tipton Street, Seymour, IN 47274-2363 Ph: (812) 524-8346 | Dr Jeffrey E Schulz, MD Schneck Medical Center, 411 West Tipton Street, Seymour, IN 47274 Ph: (812) 524-8346 |
News Archive
Medical Services International Inc. has announced that the interest by regulatory authorities and the company's distributors has increased substantially for its VScan Dengue Fever and Malaria test kits.
The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
It seems like a no-brainer, and it is: Take the junk food out of school vending machines and cafeterias, and kids will eat less junk food, according to a new study that took place in Connecticut.
Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a cytotoxicity study of its lead compound, Adva-27a, in H69AR, a Multidrug Resistant Small Cell Lung Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro.
› Verified 2 days ago
Richard Allen Wiethoff, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 S Pine St Suite 310, Seymour, IN 47274 Phone: 812-522-2177 Fax: 812-522-4069 | |
Dr. Amanda Marie Dick, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Schneck Professional Building, 411 West Tipton Street, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Gerald Brandon Millick, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Schneck Professional Building, 411 West Tipton Street, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Susan M. Maurer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Joyce Renee Iwema, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Schneck Surgical Associates, 411 West Tipton Street, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Antonio D. Spates, Surgery Medicare: Medicare Enrolled Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 |